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Context: Comparedwith glucose-sweetened beverages, consumption of fructose-sweetened bev-
erages with meals elevates postprandial plasma triglycerides and lowers 24-h insulin and leptin
profiles in normal-weight women. The effects of fructose, compared with glucose, ingestion on
metabolic profiles in obese subjects has not been studied.
Objective: The objective of the study was to compare the effects of fructose- and glucose-sweet-
ened beverages consumed with meals on hormones and metabolic substrates in obese subjects.
Design and Setting: The study had a within-subject design conducted in the clinical and transla-
tional research center.
Participants:Participants included17obesemen (n9) andwomen (n8),withabodymass index
greater than 30 kg/m2.
Interventions: Subjects were studied under two conditions involving ingestion of mixed nutrient
meals with either glucose-sweetened beverages or fructose-sweetened beverages. The beverages
provided 30% of total kilocalories. Blood samples were collected over 24 h.
Main Outcome Measures: Area under the curve (24 h AUC) for glucose, lactate, insulin, leptin,
ghrelin, uric acid, triglycerides (TGs), and free fatty acids was measured.
Results: Compared with glucose-sweetened beverages, fructose consumption was associated with
lower AUCs for insulin (1052.6 135.1 vs. 549.2 79.7 U/ml per 23 h, P 0.001) and leptin (151.9
22.7 vs. 107.0 15.0 ng/ml per 24 h, P 0.03) and increasedAUC for TG (242.3 96.8 vs. 704.3 124.4
mg/dl per 24 h, P 0.0001). Insulin-resistant subjects exhibited larger 24-h TG profiles (P 0.03).
Conclusions: In obese subjects, consumption of fructose-sweetened beverages with meals was asso-
ciated with less insulin secretion, blunted diurnal leptin profiles, and increased postprandial TG con-
centrations comparedwith glucose consumption. Increases of TGswere augmented in obese subjects
with insulin resistance, suggesting that fructose consumption may exacerbate an already adverse
metabolic profile present in many obese subjects. (J Clin Endocrinol Metab 94: 1562–1569, 2009)
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Consumption of fructose has increased dramatically over thepast 4 decades due to itswidespread use inmany foods and
beverages sweetened with sucrose (50% fructose) or high fruc-
tose corn syrup (42–55% fructose) (1). The increase of fructose
consumption parallels the increased incidence of obesity in the
U.S. population leading some investigators to suggest that di-
etary fructose contributes to increased body weight (2, 3). Fruc-
tosedoes in fact have specificmetabolic characteristics that could
potentially contribute to a metabolic profile associated with in-
creased body adiposity and the insulin resistance (metabolic)
syndrome. For example, fructose does not stimulate insulin se-
cretion (4) and plasma glucose and insulin responses are blunted
when fructose compared with glucose-sweetened beverages are
consumed with meals (5). As we previously demonstrated, these
reductions in meal-induced insulin secretion result in attenuated
diurnal circulating leptin profiles (6) due to the dependence of
leptin production on insulin-mediated glucose metabolism (7).
Reduced postprandial insulin levels also may contribute to
blunted postprandial suppression of the putative orexigenic hor-
mone ghrelin after ingestion of fructose-containing beverages
compared with glucose-containing beverages with meals (5).
Thus, fructose ingestion elicits an endocrine profile that could
potentially favor increased energy intake and weight gain by
attenuating levels of insulin and leptin, two hormones that in-
hibit food intake and contribute to the long-term regulation of
energy balance and body adiposity through actions in the central
nervous system (8). Furthermore, the fructose-induced impair-
ment in postprandial suppression of ghrelin, a hormone that
increases hunger and food intake and has been proposed to be
involved in meal initiation in humans may also contribute to
increased food intake (9, 10).
The second characteristic of fructose that has important met-
abolic implications is the site and mechanism of fructose metab-
olism. Fructosemetabolismoccurs primarily in the liver inwhich
it is phosphorylated to fructose-1-phosphate andmetabolized to
produce the triose phosphates, glyceraldehyde, and dihydroxy-
acetone and via conversion of pyruvate to acetyl-CoA by the
mitochondria, which exports citrate to the cytosol for fatty acid
synthesis (11). In contrast to glucose metabolism, which is con-
trolled by the rate-limiting enzyme phosphofructokinase and
subject to negative feedback control by elevated cytosolic levels
ofATPandcitrate, fructosemetabolism is relativelyunregulated.
Thus, after ingestion of large amounts of fructose, increases of
hepatic acetyl-CoA lead to increased production of very low-
density lipoprotein and triglycerides (TGs) (12). We previously
reported that circulating TG concentrations were substantially
elevated over a 24-h period in normal-weight, healthy women
after consumption of fructose-sweetened beverages compared
with isocaloric glucose-sweetened beverages, ingested with
mixed nutrient meals (5). Furthermore, other studies demon-
strated that fructose promotes lipogenesis (12, 13). A direct re-
lationship between fructose ingestion and elevated postprandial
triglyceride levels has important clinical implications because
elevated postprandial TG concentrations are known predictors
of cardiovascular disease (CVD) (14). If obese individuals al-
ready at risk for CVD, exhibit a similarly increased postprandial
TG response to fructose consumption as in normal weight sub-
jects, then overconsumptionof dietary fructose could exacerbate
their predisposition to development of metabolic syndrome and
CVD. In the present study, using a within-subject crossover de-
sign, we compared the endocrine andmetabolic consequences of
consuming fructose-sweetened beverages to glucose-sweetened
beverages consumed with mixed-nutrient meals on circulating
concentrations of glucose, lactate, insulin, leptin, ghrelin, uric
acid, free fatty acids, and TGs over a 24-h period in obese men
and women. We hypothesized that compared with glucose, in-
gestion of fructose would elicit greater increases of postprandial
TG concentrations and that this effect would be exacerbated in
insulin-resistant subjects.
Subjects and Methods
Subjects
A total of 17 obese subjects participated in the study. This included
eight obesewomenwith amean age of 272yr (range 18–36) andmean
bodymass index of 34.7 1.0 kg/m2 (range 31–38) and nine obese men
with a mean age of 39  3 yr (range 25–49) and body mass index of
34.5  1.0 kg/m2 (range 30–38). Subjects were recruited through ad-
vertisements in newspapers and on the Internet. Prospective subjects
were screened during an initial telephone interview and then scheduled
for an appointment at theMonell Chemical Senses Center, at which they
gave informed consent to participate in the study and were weighed and
percent body fat determined using bioelectrical impedance analysis (RJL
Systems, Mt. Clemens, MI). After the initial interview and consenting,
subjects were given a physical examination at the Clinical and Transla-
tional Research Center of the University of Pennsylvania (CTRC), in-
cluding an electrocardiogramandamedical history to ensure the absence
of chronic illnesses. The women were given a pregnancy test and ex-
cluded from the study if they were pregnant. During the physical exam-
ination, a blood sample was drawn and a standardized oral glucose
tolerance test was administered. Only subjects with fasting triglyceride
concentrations less than 200 mg/dl, fasting glucose less than 90 mg/dl,
hemoglobin 12 or greater, and blood pressure less than 150/99 mm Hg
andwith no history of chronic illness including diabetes were enrolled in
the study. The only medication permitted for participation in the study
was hormonal birth control. The studywas approved by theCommittees
on Studies Involving Human Subjects at the University of Pennsylvania
(Philadelphia, PA) and the Institutional Review Board at the University
of California, Davis (Davis, CA). One male subject dropped out of the
study without completing both trials and his data were not included in
the results.
Experimental protocol
Each subject was studied under two separate experimental condi-
tions, administered in a random order. Each experimental condition
involved a 2-night stay at the CTRC and was spaced 1 month apart.
During each inpatient stay, bloodwas sampled over a 24-h period during
which the diet was controlled. The experimental conditions were iden-
tical except for the sweetener used in the beverages. Subjects consumed
identical mixed-nutrient meals (described below) and either a glucose-
sweetened beverage (HGl) or a fructose-sweetened beverage (HFr). Fe-
male subjects were studied during the first 7 d of their menstrual cycle.
The participants were instructed to maintain their usual dietary and
exercise habits during themonthbetween the study sessions.During each
experimental session, subjects arrived at theCTRCof theHospital of the
University of Pennsylvania at 1700 h, during which time another preg-
nancy test was administered to all of the female subjects. After a stan-
dardized dinner at 1800 h, the subjects remained fasted until the follow-
ing morning. At 0730 h the next morning, an iv catheter was inserted in
the antecubital vein and kept patent with a slow saline infusion. Blood
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sampling then commenced at 0800 h and continued for 24 h, until the
following day (d2) at 0800 h. Blood samples for hormone andmetabolic
substrate measurements were collected before and while the subjects
consumed three standardizedmeals, eachaccompaniedby either theHGl
or HFr beverages.
Diets
Each subject ingested three meals per day. The energy content of the
meals was based on an estimate of that individual’s daily energy require-
ments estimated by the Mifflin equation with an activity factor of 1.2.
Caloric distribution over the day was 25% of kilocalories for breakfast,
35% for lunch and 40% for dinner. The meals provided 30% energy
from fat, 15% from protein, and 55% from carbohydrate. Of the 55%
of total energy intake provided by carbohydrate, 25%was derived from
complex carbohydrate and30%for either glucose or fructose in the form
of the beverages. Beverageswere prepared as 15%solutions and flavored
with a popular unsweetened drinkmix. As an example, for an individual
requiring 1800 kcal/d, the volume of each beverage at each meal would
be 300 ml. Diets and beverages were identical with those used in our
previous study (5).
Blood sampling
Blood sampling began at 0800 h of d 1 of the study and continued for
24 h until 0800 h of d 2 of the study. Three baseline samples, collected
at 0800, 0830, and 0900 h,were drawn, and the remaining sampleswere
takeneveryhour, except aftermeals andduring theanticipatednocturnal
peak of circulating leptin concentrations (which typically occurs 5–9 h
after the evening meal). For the 2 h after each meal (0900–1100, 1300–
1500, and 1800–2000 h) and the 4 h around the nocturnal leptin peak
(2300–0300h), blood sampleswere collected every half-hour, for a total
of 36 blood samples collected over the 24-h period. Each sample con-
sisted of thewithdrawal of 1ml of blood to clear the catheter tubing, and
5 ml of blood collected into Vacutainer tubes (Becton, Dickinson and
Co., Franklin Lakes, NJ) containing EDTA. To inhibit proteolysis, each
blood sample was then mixed with an inhibitor of dipeptidyl peptidase
IV (Linco Research, Inc., St. Charles, MO), and protease inhibitor cock-
tails containing Trasylol and leupeptin (10 l/ml of whole blood of the
protease inhibitor cocktails and dipeptidyl peptidase IV inhibitor) were
added as recommended by the distributor. The samples were kept on ice
for nomore than 1 h and were then centrifuged, aliquoted, and stored at
70 C until assayed.
Assays and data analysis
Plasma glucose and lactate were measured in duplicate using a YSI
2300 StatPlus glucose analyzer (Yellow Springs Instruments, Yellow
Springs, OH). Plasma insulin was measured in duplicate by double an-
tibodyRIAwith human specific antibodies (LincoResearch). The insulin
assayswere performed by theDiabetesResearchCenter of theUniversity
of Pennsylvania. Plasma leptin was measured with a RIA for human
leptin with reagents (Linco Research). Plasma TG was measured in
triplicate with reagents from Sigma (St. Louis, MO), and free fatty
acid was measured with reagents from Wako (Richmond, VA). Total
plasma ghrelin was measured without extraction with an RIA (Phoenix
Pharmaceuticals, Inc., Burlingame, CA). Uric acid was measured with
reagents from Thermo Scientific (Pittsburgh, PA).
A plasma fructose assay was developed to measure plasma fructose
concentrations through amodification of a commercial glucose/fructose
analysis kit (Megazyme, catalog no. K-FRUGL; Xygen Diagnostics Inc.,
Burgessville, Ontario, Canada). Details of themethodology are reported
in the study by Adams et al. (15).
The area under the curve (AUC)was calculated for all variables using
the Origin Software (version 7; Northhampton, MA). For glucose, lac-
tate, leptin, TGs, and uric acid, themean of the three baseline values was
determined, and net AUCwas calculated by subtracting the areas below
baseline from AUC values above baseline. AUCs for glucose, lactate,
leptin, TGs, and uric acid are expressed as units per 23 h above each
subject’s fasting baseline levels because the first hour of sampling deter-
mined the baseline levels. For free fatty acids and ghrelin, because these
two variables drop below baseline, the AUC below baseline is included
to avoid negative numbers. The nadirs and peaks for plasma leptin were
determined as the mean of two lowest consecutive morning concentra-
tions before 1200 h and themean of the two highest consecutive nighttime
concentrations after 2000h, respectively. TheAUCs for leptin are therefore
expressedasunits above each subject’s nadir over24h.Differencesbetween
AUCs for the two diets were determined with paired t tests.
The homeostasis model assessment of insulin resistance (HOMA-IR)
was calculated from the means of the glucose and insulin concentra-
tions in three baseline samples using the original model (16) [fasting
plasma insulin (microunits per milliliter)  fasting plasma glucose
(millimoles/22.5)].
To determine the effects of insulin resistance and interactions be-
tween insulin resistance and the experimental conditions, treatment
time  insulin resistance interactions were evaluated using repeated-
measures ANOVA. Post hoc analysis was conducted using Tukey’s
test. Sex effects were also evaluated using sex as a factor in place of
insulin resistance. Statistical significance was considered at P 0.05.
Results
Plasma glucose, fructose, lactate, and free fatty acids
Fructosewas undetectable in plasma samples collected on the
day of HGl consumption. However, on the day that HFr bever-
ageswere consumed,plasma fructose concentration increasedby
approximately 0.5 mM after consumption of the fructose bever-
ages with meals (Fig. 1A). Baseline fasting glucose concentra-
tions were not significantly different between the HGl and HFr
days averaging (4.6  0.1, 4.7  0.1 mM). After ingestion of
fructose beverages with the meals, plasma glucose concentra-
tions increased significantly by approximately 1 mM but were
significantly lowerwhen comparedwith after glucose-sweetened
beverages were consumed (Fig. 1B). The AUC for glucose was
reduced by approximately 50% on the HFr compared with the
HGl day (Table 1). Plasma lactate concentrations increased much
more after ingestion of theHFr beverages (Fig. 1C) comparedwith
the HGl beverages, with the lactate AUC being more than 5 times
higher thanwhenglucose-sweetenedbeveragewere consumed (Ta-
ble 1). No significant differences were observed between plasma
free fatty acid responses (Fig. 1D), although a trend toward a lower
AUCforfree fattyacidswasobservedafterHfr (Table2),aswehave
previously reported in normal-weight women (5).
Plasma insulin, leptin, and ghrelin
Baseline fasting insulin levels were not significantly different
on the HFr and HGl days averaging 14.8 7.9 and 13.9 8.6
U/ml, respectively. Peak plasma insulin concentrations were
significantly reduced after consumption of the HFr beverages
with meals compared with levels after ingestion of the HGl bev-
erages (Fig. 2A). The AUC for insulin was reduced by approxi-
mately 50%, reflecting a similar reduction as observed for glu-
cose concentrations (Table 1). Fructose ingestion also reduced
the diurnal circulating leptin profile comparedwith glucose (Fig.
2B). The AUC for leptin was reduced by approximately 30% on
the daywhenHFr beverages comparedwithHGl beverageswere
consumed (Table 1), consistent with what we have previously
reported in normal-weight women (5). Whereas leptin levels
were significantly higher in women, no sex-by-treatment inter-
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action was observed (Table 2). In contrast with what we have
reported in normal-weight subjects (5), 24-h ghrelin AUCs were
not different on the HGl and HFr days, averaging 10532.3 
663.1 and 10405.4  597.2 pg/ml, respectively.
Plasma uric acid and TG
Baseline fastinguric acid concentrationswere4.90.2mg/dl in
women andwere slightly higher inmen averaging 5.5 0.2mg/dl.
Although there was a tendency for higher postmeal peaks of uric
acid of approximately 0.5 mg/dl after HFr compared with HGl,
there was no significant difference in the AUC for uric acid con-
centrations between the HGl and HFr days (Table 1). Men and
women exhibited differential responses to the dietary treatments
because AUC for uric acid was higher after
fructose ingestion inmenbut lower inwomen
comparedwithafterglucoseingestion(Table2).
Baseline fasting TG concentrations were
not different on the HGl (84.5 10.8 mg/dl)
and HFr study days (84.0  10.5 mg/dl).
Plasma TG concentrations were significantly
elevated after ingestion of fructose-sweetened
beverages with meals (Fig. 3). The AUC for
TGs was almost 200% higher on the HFr
compared with the HGl days in men and
women together (Table 1). Fasting TG con-
centrations were higher in men (94 15 mg/
dl) compared with women (69 10) as were
the postprandial AUCs for the 24 h after fruc-
tose ingestion(Table2),butthedifferencesdid
not reach statistical significance (P 0.09).
Effect of insulin sensitivity/resistance
on metabolic and endocrine responses
To determine whether the endocrine
metabolic responses to glucose and fructose
ingestion might differ as a function of insu-
lin resistance, subjects were classified as in-
sulin sensitive if HOMA-IR was less than
2.5 and insulin resistant if HOMA-IR was
greater than 2.5. Using these criteria, 10
subjectswere categorizedas insulin sensitive
(four men, six women) with mean
HOMA-IR of 1.93  0.29 on the HGl day
and 2.05  0.47 on the HFr day. Seven subjects were classified
as insulin resistant (five men, two women) with a mean
HOMA-IR of 4.97  0.38 on the HGl day and 4.49  0.61 on
the HFr day (P  0.02 vs. insulin sensitive subjects). Baseline
fastingTGs tended to be higher in the insulin-resistant compared
with the insulin-sensitive subjects (107.0 48.7 vs. 68.8 37.5
mg/dl insulin resistant vs. insulin sensitive, HGl day, P 0.09).
Table 3 presents the AUCs for the measured parameters in sub-
jects classified as insulin sensitive vs. insulin resistant. As would
be predicted, a significant effect of insulin resistance on insulin
AUCswasobserved.Therewere significant interactions between
the effects of treatment and insulin resistance forboth insulin and
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FIG. 1. Effect of glucose-sweetened beverages (solid lines) and fructose-sweetened beverages (dashed
lines) on plasma concentrations of fructose (A), glucose (B), lactate (C), and free fatty acid levels (D) in
obese men and women consuming beverages with meals (mean  SEM, n  17). Fructose was
undetectable on the day glucose-sweetened beverages were consumed. Plasma glucose levels were
significantly lower (F  9.0, P  0.00001, time  treatment), and plasma lactate levels were elevated (F 
13.7 P  0.00001, time  treatment) after fructose compared with glucose consumption. No significant
differences were observed in plasma free fatty acid concentrations between treatments.
TABLE 1. AUC calculated above baseline (0800–0900 h) for the 23 h after the three morning baseline samples (glucose,
lactate, insulin, TG, uric acid) or including baseline (free fatty acids and ghrelin)
High glucose High fructose P
Glucose (mg/dl per 23 h) 430.6  32.0 221.4  25.3 0.0001*
Lactate (mmol/liter per 23 h) 112.3  64.2 609.0  67.1 0.0001*
Insulin (uU/ml per 23 h) 1052.6  135.1 549.2  79.7 0.0001*
Leptin (ng/ml per 24 h) 151.9  22.7 107.0  15.0 0.03*
TG (mg/dl per 23 h) 242.2  96.8 704.3  124.4 0.0001*
Free fatty acids (mmol/liter per 23 h) 411.3  73.1 383.5  64.9 0.21
Ghrelin (pg/ml per 23 h) 10532.3  663.1 10405.4  597.2 0.53
Uric acid (mg/dl per 23 h) 0.10  1.9 1.1  1.3 0.55
Leptin was calculated as the 24-h AUC above morning trough concentrations. Mean  SEM (n  17), paired t test.
*, P values are statistically significant.
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leptin (Table 3). In both cases, the effect of fructose to reduce
insulin and leptin profiles relative to glucose was greater in the
presence of insulin resistance.
Subjects with insulin resistance had significantly increased
TG responses after consumption of both glucose- and fructose-
sweetened beverages (Fig. 4). No significant interaction be-
tween insulin resistance and treatment was observed, suggest-
ing that the effect of fructose compared with glucose to
increase postprandial triglyceride profiles is consistent across
insulin-sensitive and insulin-resistant individuals (Table 3).
Discussion
Glucose, insulin, and leptin profiles
The overall objective of this study was to compare 24-h en-
docrine and metabolic profiles after the consumption of either
fructose-sweetened or glucose-sweetened beverages in conjunc-
tion with isocaloric meals in obese individuals. Consumption of
fructose-sweetened beverages with meals results in smaller post-
meal increases of plasma glucose and reduced meal-induced in-
sulin responses. This decrease of insulin secretion has further
metabolic consequences because insulin-mediated glucose me-
tabolism leading to specificity protein-1-mediated transcription
in adipocytes is an important mechanism in the regulation of
leptin production (17). After fructose ingestion, the lower glu-
cose and insulin excursion result in decreased leptin production
anda reduction in the diurnal circulating leptin profile compared
with consumption of the same amount of glucose. The decreased
insulin responses also underlie the dramatic increases of circu-
lating lactate. Reduced insulin action leads to less pyruvate en-
tering the mitochondria for oxidation and a corresponding in-
crease of anaerobic metabolism to lactate, independent of
increasing leptin production (18). Increases in lactate are typi-
cally associated with increased lipogenesis (19, 20), which has
been demonstrated after fructose administration in humans.
The amplitude of the diurnal leptin pattern has been implicated
in the effects of substituting dietary carbohydrate for fat to induce
weight loss under ad libitum conditions (21). In the present study,
we found that the reduction of the diurnal leptin profile after fruc-
tose ingestion was of comparable magnitude with that reported in
our previous studies conducted in normal-weight subjects compar-
ing the effects of high fructose and glucose diets (5) as well as high-
carbohydrate and high-fat diets (22). Taken together, these studies
indicate that 24-h circulating leptin concentrations can be reduced
by approximately 30–40%throughdietarymanipulations.Whereas
the nadir of leptin remains similar and leptin still peaks during the
lateeveninghours, therateof increaseandtheamplitudeof thepeak
are blunted after consumption of the meal
high in fructose. Both high-fat and high-fruc-
tose diets reduce insulin secretion and leptin
production aswell as increase triglyceride lev-
els relative to glucose-containing carbohy-
drate. Because insulin and leptin are two crit-
ical endocrine signals involved in themedium
to long-term regulation of body adiposity, it
has been hypothesized that diets high in fat
and/or fructose may lead to increased energy
intake and weight gain due to reductions of
insulin secretion and leptin production (23).
Ghrelin
Insupportof thehypothesis thathigh-fruc-
tose diets elicit a metabolic/endocrine profile
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FIG. 2. Effect of glucose-sweetened beverages (solid lines) andfructose-sweetened beverages (dashed lines) on
plasma concentrations of insulin (left panel) and the percent change of plasma leptin from baseline (right panel)
in obese human subjects (mean SEM, n 17). Plasma insulin (F 2.15, P 0.003, time treatment) and
leptin levels (F 2.55, P 0.00001, time treatment) were significantly lower after fructose compared with
glucose consumption. Baseline leptin values were 20.7 10.69 (HGl) and 20.3 11.0 (HFr).
TABLE 2. Effect of sex on metabolic responses to glucose- and fructose-sweetened beverages consumed with a meal
Male Female
PS PTSGlucose Fructose Glucose Fructose
Glucose (mg/dl per 23 h) 429.1  45.7 228.4  35.9 432.1  46.5 213.5  38.1 0.90 0.80
Lactate (mmol/liter per 23 h) 165.8  88.9 542.9  96.4 52.0  94.3 579.4  102.3 0.60 0.35
Insulin (U/ml per 23 h) 1156.9  187.6 731.6  94.8 935.3  199.1 343.8  100.6 0.15 0.39
Leptin (ng/ml per 24 h) 109.1  27.9 80.0  19.2 200.0  29.6 139.0  20.4 0.02* 0.43
TG (mg/d per 23 h) 408.5  122.3 774.9  145.0 55.0  129.7 473.2  153.8 0.09 0.74
Free fatty acids (mmol/liter per 23 h) 403.1  24.9 425.2  15.0 420.6  26.5 336.6  16.1 0.17 0.08
Ghrelin (pg/ml per 23 h) 9735.6  892.1 9594.5  790.8 11428.5  946.3 11317.6  838.8 0.18 0.94
Uric acid (mg/dl per 23 h) 4.8  2.1 0.65  1.9 5.1  2.2 1.6  1.9 0.04* 0.02*
AUC calculated above baseline (0800–0900 h) for the 23 h after the three morning baseline samples (glucose, lactate, insulin, TG, uric acid) or including baseline (free
fatty acids and ghrelin). Leptin AUC was calculated as the 24-h AUC above morning trough concentrations. Mean SE (male, n  9; female, n  8). PS, P value for effect
of sex; PTS, P value for treatment  sex interaction, statistical significance if P  0.05.
*, P values are statistically significant.
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that would promote increased food intake, in our previous study,
we reported an attenuated postprandial suppression of the orexi-
genic hormone ghrelin after high-fructose meals compared with
high-glucose meals in normal-weight women (5). The decreased
suppression of ghrelin after fructose consumption was most likely
also a consequence of the smaller glucose and insulin excursions
because insulin-mediated glucose metabolism has been implicated
inthepostprandial suppressionofghrelinandthedifferential effects
of dietary macronutrients on this suppression (24, 25). In the
present study conducted in obese subjects, therewere no significant
differences in 24-h circulating ghrelin concentrations when com-
paring fructose- with glucose-sweetened beverage consumption.
The effects of meal ingestion to suppress plasma ghrelin levels has
been reported to be blunted in obese subjects (26, 27), and it is
possible that this is why differences between the effects of glucose
and fructosewerenot observed (28, 29) as occurs innormal-weight
subjects. In normal-weight subjects, plasmaghrelinwas reducedby
approximately35%aftereachhigh-glucosemeal,but in thecurrent
study, the postmeal suppression of ghrelin averaged only around
15% in obese subjects. Although some investigators have reported
blunted ghrelin levels in obese insulin-resistant subjects but not
obese insulin sensitive subjects (30), 24-h ghrelin profiles did not
differbetween insulin-sensitive and -resistant subjects in the current
study.
TGs
CirculatingTG concentrationswere significantly increased
after fructose compared with glucose consumption. Increased
circulating TGs after ingestion of diets high in fructose has
been reported previously in animal studies as well as normal-
weight humans (23) and reflects the absence of regulatory
controls involved in the uptake and metabolism of fructose by
the liver. The rapid clearance and metabolism of fructose to
lactate as demonstrated by relatively low levels of circulating
fructose and marked increases of lactate after fructose iv ad-
ministration has also been recently reported in rhesus mon-
keys (15). The hepatic metabolismof fructose results in increased
availability of triose phosphate for glycerol and acetyl Co-A of pre-
cursors for fatty acid and TG production and export to the circu-
lation (23). Increases in postprandial fructose may also result from
increased reesterification of TGs derived from the diet (31).
Postprandial TGs were increased by fructose compared with
glucose in both insulin-sensitive and insulin-resistant subjects.
Subjects with insulin resistance had significantly increased TG
responses, consistent with the larger postprandial TG responses
reported in insulin-resistant subjects and those with elevated
fasting TGs. HOMA-IR is derived from fasting levels of glucose
and insulin concentrations, and elevated HOMA-IR values are
considered to reflect hepatic insulin resistance. Thus, subjects
with hepatic insulin resistance, and associated increases in basal
lipogenesis, have exacerbated hypertriglyceridemic responses to
acute fructose and glucose ingestion. Because elevated postpran-
dial TGs are associated with increased CVD (14, 32), these
results suggest that obese individuals, particularly those with
insulin resistance or elevated TG levels, should avoid over-
consumption of foods and beverages containing fructose.
Dietary fructose has also been shown to increase circulating
concentrations of uric acid, a purine metabolite independently
associated with the metabolic syndrome (33–35). The hypoth-
TABLE 3. Effect of insulin resistance on metabolic responses to glucose- and fructose-sweetened beverages consumed with a
meal
Insulin sensitive Insulin resistant
PR PTRGlucose Fructose Glucose Fructose
Glucose (mg/dl per 23 h) 425.2  43.3 225.6  34.1 438.1  51.7 215.3  40.7 0.97 0.75
Lactate (mmol/liter per 23 h) 124.1  86.4 635.4  90.4 95.4  103.3 573.4  108.0 0.69 0.83
Insulin (U/ml per 23 h) 706.9  117.2 412.9  90.6 1546.4  140.0 760.4  108.3 0.01* 0.01*
Leptin (ng/ml per 24 h) 131.8  29.5 119.3  20.2 180.6  35.3 91.2  24.1 0.77 0.03*
TG (mg/dl per 23 h) 73.1  111.2 460.2  129.1 483.6  132.9 879.7  154.3 0.03* 0.95
Free fatty acids (mmol/liter per 23 h) 415  23.8 369.5  20.4 405.6  28.7 403.4  24.4 0.65 0.33
Ghrelin (pg/ml per 23 h) 10,322.2  888.8 10,366.9  865.3 10,832.4  1062.4 10,460.2  960.9 0.81 0.51
Uric acid (mg/dl per 23 h) 0.19  2.6 0.71  1.7 0.02  3.1 1.6  2.1 0.84 0.86
AUC calculated above baseline (0800–0900 h) for the 23 h after the three morning baseline samples (glucose, lactate, insulin, TG, uric acid) or including baseline (free
fatty acids and ghrelin). Leptin was calculated as the 24-h AUC above morning trough concentrations. Mean  SEM (insulin sensitive: HOMA  2.5, n  10; insulin
resistant: HOMA  2.5, n  7). PR, P value for effect of resistance; PTR, P value for treatment  insulin resistance interaction.
*, P values are statistically significant.
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FIG. 3. Effect of glucose-sweetened beverages (solid lines) and fructose-
sweetened beverages (dashed lines) on plasma TG concentrations in obese
subjects (mean  SEM, n  17). Plasma TG levels were significantly elevated after
fructose compared with glucose consumption. (F  4.99 P  0.0001,
treatment  time interaction).
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esized mechanism mediating the increase in uric acid after fruc-
tose ingestion is thought to be due to an increase of intracellular
ADP levels resulting from the phosphorylation of fructose-1-
phosphate by fructokinase. In the present study, we did not find
significant differences in the 24 h uric acid profiles (AUCs) be-
tween the days when fructose and glucose-sweetened beverages
were consumed (Table 1), although there was a trend for small
postmeal increases of around 0.5 mg/dl with fructose but not
glucose. However, there were statistically significant sex differ-
ences and sex-by-treatment interactions (P0.01).TheAUCfor
uric acid in men after glucose was 4.8  2.1 mg/dl (23 h)
comparedwith 0.651.9mg/dl (23 h) after fructose. Inwomen,
AUCafter glucosewas5.12.2mg/dl (23h inwomen,P0.04)
and 1.56  1.9 (after the HFr condition). Sex differences in the
effects of added sugars or sugar-sweetenedbeverages onuric acid
concentrations have been reported with significant effects ob-
served in men but not women (36). Other studies have also re-
ported relationships between uric acid and TG levels. For ex-
ample, inhibiting increases in uric acid by administration of
allopurinol also inhibits the increase in TG levels in rats on a
high-fructose diet; however, this effect has not been observed in
some human studies (37, 38). Whereas the mechanism of the
relationship among fructose, TGs, and uric acid has not been
established, some investigators have hypothesized that uric acid
elevates TGs by inhibiting TG clearance. In the present study,
uric acid and TG levels were not correlated during either the
high-glucose or high-fructose study days. It is possible that ele-
vations in uric acid levels require prolonged and sustained in-
creases in plasma fructose, which did not occur with this study
design.
Very few studies have reported the plasma fructose concen-
trations after ingestion of dietary fructose, and measurements
of fructose can facilitate understanding of the metabolic fate of
fructose in the postprandial state. In this study, increases of
plasma fructose when a large fructose sweetened beverage was
consumed in the context of amixedmeal averaged 0.15–0.3mM
and were only approximately 5% of the increase of circulating
glucose levels after ingestion of the same amount of glucose.
Within 3 h after consumption of the high-fructose beverages,
fructose concentrations were below the detection limit of the
assay. As expected, fructose was undetectable in the circulation
on the day that glucose-sweetened bever-
ages were consumed. We recently reported
low levels of fructose during in a study com-
paring the effects of iv fructose and glucose
infusions in rhesus monkeys (15), again re-
flecting the rapid metabolism of fructose by
the liver, evenwhen fructose is administered
systemically rather than entering via the
portal circulation.
It has been argued that the results from
studies examining the effect of fructose
alone may not be applicable to the effects of
fructose in a normal diet, which typically
contains fructose in the form of sucrose, a
disaccharide composed of 50% glucose and
50% fructose and high-fructose corn syrup
composed of 55%glucose and 45% fructose. However, recently
published data from our laboratory suggest that even when the
amount of fructose is diluted by the presence of glucose such as
occurs in the form of sucrose or high-fructose corn syrup, 24-h
TGprofiles are elevated to the same extent aswith fructose alone
(39). Thus, fructose, in the presence of glucose, appears to in-
crease hepatic TG production and postprandial TG concentra-
tions. Additional short-term and long-term dose-response stud-
ies in both metabolically normal and at-risk subjects will be
required to determine the amounts of dietary fructose that have
adverse effects on lipid metabolism in different populations.
In summary, we compared the effect of the twomonosaccha-
rides, glucose and fructose, consumed in the form of sweetened
beverages with isocaloric mixed nutrient meals on circulating
hormones and lipids in obese men and women. In comparison
with glucose, consumption of fructose-sweetened beverages re-
sults in decreased insulin secretion, a reduced diurnal leptin pro-
file, and increased postprandial TG concentrations in obese in-
dividuals, independent of insulin sensitivity. In addition, the
effect of fructose to increase TGs was augmented in obese sub-
jects with insulin resistance. Epidemiological studies support an
association between fructose intake and increased risk of type 2
diabetes mellitus (40). Together with the present results, these
data suggest that overconsumption of dietary fructose may ex-
acerbate the adversemetabolic profiles in obese individuals, par-
ticularly those with existing insulin resistance andmay therefore
increase the risks for developing diabetes and CVD.
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FIG. 4. TG responses to consumption of glucose-sweetened (left panel) and fructose-sweetened
beverages (right panel) with meals in insulin-sensitive (n  10, dashed line, round symbol) and insulin-
resistant obese subjects (n  7, solid line, square symbol). Plasma TG concentrations were significantly
elevated after fructose consumption in both insulin-sensitive and insulin-resistant subjects (F  5.1, P 
0.0001, treatment  time).
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